Despite medical advancements, cancer's grip on Flanders' mortality rates persists. An analysis of the 2023 mortality data by the Department of Care reveals a complex picture. While overall mortality has decreased compared to the previous year, and life expectancy is on the rise, cancer remains the top killer.
Since 2018, cancer has been the leading cause of death in Flanders, but there's a silver lining: the number of cancer-related deaths is on a gradual decline. However, the most significant drop is observed in cardiovascular diseases, which have traditionally been the biggest threat to life. This is a promising trend, but it also raises questions about the factors contributing to this decrease.
In 2023, Flanders witnessed 63,941 deaths, but when adjusted for the ageing population, this marks the lowest mortality rate in 10 years. And here's where it gets intriguing: men are still significantly more likely to die than women, a pattern that warrants further investigation.
Life expectancy is on the upswing, with boys born in 2023 expected to live until 81.4 years and girls until 85.1 years. But the disparity between genders persists, as men lose 1.6 times more years of life due to premature death than women, with cancer and cardiovascular diseases leading the way. This begs the question: why the persistent gap?
The study also highlights a gender difference in the location of death. Almost half of male deaths occurred in hospitals, while for women, residential care facilities were the most common setting, accounting for 41% of deaths. This variation may be linked to the higher proportion of older women in the population.
FlandersNewsService | © PHOTO PRESS ASSOCIATION
What do these trends suggest about the state of healthcare and society in Flanders? Are the gender disparities in mortality rates and life expectancy a cause for concern? Share your insights and opinions in the comments below!
